ALX ONCOLOGY HOLDINGS INC Fair Value Adjustment of Warrants
ALX ONCOLOGY HOLDINGS INC (ALXO) reported Fair Value Adjustment of Warrants of $8.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-02-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2022-02-28
- ALX ONCOLOGY HOLDINGS INC fair value adjustment of warrants for the quarter ending 2020-12-31 was $0.00.
- ALX ONCOLOGY HOLDINGS INC fair value adjustment of warrants for the quarter ending 2020-09-30 was $21.00K.
- ALX ONCOLOGY HOLDINGS INC fair value adjustment of warrants for the quarter ending 2020-06-30 was $309.00K.
- ALX ONCOLOGY HOLDINGS INC fair value adjustment of warrants for fiscal 2020 was $8.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $21.00K derived: sum of 2 quarters · filed 2022-02-28 | $330.00K derived: sum of 3 quarters · filed 2022-02-28 | $8.00K 10-K · filed 2022-02-28 |
| 2020-09-30 | $21.00K 10-Q · filed 2021-11-12 | $330.00K derived: sum of 2 quarters · filed 2021-11-12 | $8.00K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $309.00K 10-Q · filed 2021-08-12 | $395.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |